Saturday 17 October 2026 Export IART’s income statement to Excel — free account

Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.6 billion, up 1.53% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 101.0%, free cash flow grew 193.5% and total debt rose 1.51%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

13.21 0.32 −2.37%

Follow IART

Alert me

Market cap: $1.1B
P/E: 0.0×
Fwd P/E: 26.1×
Dividend yield: —
F-score: 5/9
Altman Z: 0.62
Beneish M: −3.25
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		0.67	0.58	0.44	0.84
P/FCF ratio Full definition →		0.00	0.00	177.67	53.80
P/Operating CF Full definition →		26.89	80.59	73.94	60.88
P/B ratio Full definition →		1.06	0.91	0.70	1.33
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		1.95	1.53	1.44	1.84
EV/EBITDA Full definition →		0.00	0.00	0.00	13.56
EV/Operating CF Full definition →		35.82	49.74	33.23	35.52
EV/FCF Full definition →		(708.68)	(80.70)	581.82	117.46
Quick Ratio Full definition →		1.46	1.19	1.53	1.64
Current Ratio Full definition →		3.14	2.54	3.38	3.60
Net Debt/EBITDA Full definition →		29.55	24.86	30.67	26.60
Debt/Assets Full definition →		49.15%	50.45%	51.06%	51.32%
Debt/Equity Full definition →		1.73	1.74	1.75	1.75
Asset Turnover Full definition →		0.43	0.43	0.43	0.46
Operating CF/Net income Full definition →		(7.57)	(6.93)	(2.12)	5.09
Capex/Depreciation Full definition →		(0.38)	(0.44)	(0.38)	(0.31)
Interest Coverage Full definition →		0.52	0.97	0.51	0.84
Research and Development Expense of Revenue Full definition →		5.59%	5.70%	6.00%	5.79%
Selling, General and Administrative Expense of Revenue Full definition →		42.04%	38.92%	45.48%	41.18%
Intangible Assets out of Total Assets Full definition →		0.49	0.49	0.48	0.47
Share Based Compensation of Revenue Full definition →		1.39%	1.34%	1.32%	1.40%
Graham Net Nets Full definition →		(1.33)	(1.47)	(1.88)	(0.96)
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(45.08%)	(54.19%)	(68.58%)	(0.50%)
Free Cash Flow Yield Full definition →		(0.41%)	(3.26%)	0.56%	1.86%
Revenue per Share Full definition →		5.24	5.67	5.09	5.42
Operating CF per Share Full definition →		0.53	0.15	0.13	0.30
Capex per Share Full definition →		(0.20)	(0.22)	(0.19)	(0.16)
Free Cash Flow per Share Full definition →		0.34	(0.07)	(0.07)	0.14
Cash per Share Full definition →		3.49	3.44	3.45	3.55
Shareholders Equity per Share Full definition →		13.52	13.61	13.55	13.50
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		13.52	13.61	13.55	13.50
Free Cash Flow Full definition →		25.75	(5.40)	(5.04)	10.50
Working Capital Full definition →		779.53	703.56	825.17	860.60
Capital Expenditures Full definition →		(15.16)	(17.21)	(14.85)	(12.31)
Net Current Asset Value Full definition →		(1,465.30)	(1,398.99)	(1,363.30)	(1,328.63)
EV/EBIT Full definition →		0.00	0.00	0.00	46.23
Capex to Sales Full definition →		0.04	0.04	0.04	0.03
Price to Operating Income Full definition →		0.00	0.00	0.00	21.18
Other line items
Average Receivables Full definition →		255.23	275.61	258.43	275.85
Average Payables Full definition →		84.99	89.11	89.62	87.74
Average Inventory Full definition →		463.02	460.91	470.23	478.57
Average Assets Full definition →		3,856.13	3,819.71	3,815.24	3,615.70
Average Common Equity Full definition →		1,279.58	1,294.37	1,283.27	1,041.02

Show all line items

Columns are period end dates

Stockrow Weekly